Optical Genome Mapping and NGS Integration for Clinical Research in Leukemia and Lymphoma

Explore the integration of Optical Genome Mapping with Next-Generation Sequencing for clinical research in leukemia and lymphoma in this 45-minute panel discussion from the 2022 Cancer Genomics Consortium Annual Meeting. Gain insights from experts Yassmine Akkari, Rashmi Kanagal-Shamanna, Ravindra Kolhe, and Brynn Levy as they discuss the latest advancements in cancer genomics. Learn about the potential of these combined technologies to improve accurate diagnosis and personalized treatment for cancer patients. Discover how the Cancer Genomics Consortium promotes best practices in clinical cancer genomics and their vision for enhancing patient care through genomic testing.